# Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients

> **NCT01364324** · — · COMPLETED · sponsor: **National Cancer Center, Korea** · enrollment: 40 (actual)

## Conditions studied

- Tuberculosis
- Tuberculosis, Pulmonary
- Early Gastric Cancer

## Interventions

- **DRUG:** standard first line anti-TB drugs

## Key facts

- **NCT ID:** NCT01364324
- **Lead sponsor:** National Cancer Center, Korea
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2020-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01364324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01364324, "Pharmacokinetics of Anti-tuberculosis Drugs in Gastrectomized Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01364324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*